Skip to main content
EastWest Bioscience Inc. logo

EastWest Bioscience Inc. — Investor Relations & Filings

Ticker · EAST.H ISIN · CA27783V1076 TSXV Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2022-08-12 Regulatory Filings
Country CA Canada
Listing TSXV EAST.H

About EastWest Bioscience Inc.

https://www.eastwestbioscience.com/

EastWest Bioscience Inc. is a vertically integrated wellness company operating on a seed-to-sale model. It specializes in the sourcing, manufacturing, branding, marketing, and distribution of multiple lines of premium hemp and CBD consumer goods. The company owns and operates retail and manufacturing subsidiaries, including an award-winning natural health retail unit. Its manufacturing capabilities include custom blends and production runs for top-quality wellness products, supported by Health Canada certified facilities and infrastructure designed for global distribution in the consumer health market.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-08-12 English
News release - English.PDF
Major Shareholding Notification Classification · 100% confidence The document is a press release titled 'Early Warning Report in accordance with National Instrument 62-103' and details a direct acquisition of shares by a company officer, Ms. Ciska Asriel, who is COO and CFO. It specifies the number of shares owned before and after the transaction and the percentage ownership. This matches the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels. The document is short and focused on share acquisition by an insider, not a full report or financial statement. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2022-08-11 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release from EastWest Bioscience reporting a material increase in earnings recognition due to the deconsolidation of a subsidiary. It discusses financial events such as a financing round, loss of control of a subsidiary, and recognition of gains. It also provides operational updates on the subsidiary and background information about the company. The document does not contain detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more of a financial update and operational announcement. The length is 7092 characters, which is sufficient for a detailed announcement but not a full financial report. The content focuses on financing activities and changes in capital structure (loss of control of subsidiary, financing round). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-04-06 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled as a "Notice of Annual and Special Meeting of Shareholders" and includes a "Management Information Circular and Proxy Statement" for EastWest Bioscience Inc. It details the agenda for the shareholders' meeting, including election of directors, appointment of auditors, and approval of a stock option plan. It also provides instructions on proxy voting and information for beneficial shareholders. The content is typical of materials sent to shareholders to inform them about the upcoming annual general meeting and to solicit their votes. This matches the definition of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not a report of voting results, nor is it the actual annual report or financial statements. It is also not a brief announcement or a presentation. Therefore, the correct classification is PSI with high confidence.
2022-02-28 English
Form of proxy - English.pdf
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General and Special Meeting of Eastwest Bioscience Inc. It includes instructions for appointing a proxyholder, voting methods, and voting recommendations on various agenda items such as fixing the number of directors, election of directors, appointment of auditors, and approval of a stock option plan. The document is clearly related to the organization and conduct of a shareholder meeting, specifically the Annual General Meeting (AGM). It does not contain financial statements or detailed financial analysis, nor is it a transcript or announcement of financial results. It is not a report but rather proxy solicitation materials for the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (7701 characters) and content confirm it is a proxy form and related AGM materials, not a report publication announcement or regulatory filing.
2022-02-28 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual and Special Meeting of Shareholders for EastWest Bioscience Inc. It details the date, location, agenda items such as election of directors, appointment of auditors, and approval of stock option plan. It also includes instructions for proxy voting and shareholder participation. The document is a formal notice to shareholders about the upcoming meeting and does not contain financial statements, management discussion, or voting results. It is not a report or transcript but a notification of the meeting itself. Therefore, it fits the category of AGM Information (AGM-R). The document length is under 5,000 characters and is clearly a meeting notice, not a report publication announcement or proxy solicitation material.
2022-02-28 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.